Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
137,278,139
-
Total 13F shares
-
85,588,569
-
Share change
-
+557,088
-
Total reported value
-
$1,650,323,775
-
Put/Call ratio
-
96%
-
Price per share
-
$19.28
-
Number of holders
-
200
-
Value change
-
-$5,282,843
-
Number of buys
-
124
-
Number of sells
-
77
Institutional Holders of Vir Biotechnology, Inc. - Common Stock (VIR) as of Q3 2022
As of 30 Sep 2022,
Vir Biotechnology, Inc. - Common Stock (VIR) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
85,588,569 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, STATE STREET CORP, BAILLIE GIFFORD & CO, ALLIANCEBERNSTEIN L.P., Bill & Melinda Gates Foundation, RENAISSANCE TECHNOLOGIES LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
203
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.